Mogher Khamaisi, MD, PhD, is Director of the Department of Internal Medicine “D” at Rambam Health Care Campus. He is also an Associate Professor at the Rappaport Faculty of Medicine of the Technion-Israel Institute of Technology, where he conducts basic and clinical research.
Dr. Khamaisi completed B.S., M.Sc., and Ph.D. degrees in biology from Ben-Gurion University in Beer Sheva, all with honors. He graduated from Ben-Gurion University Medical School and completed his residency in the Department of Internal Medicine “B” at Hadassah Hospital Ein-Kerem in Jerusalem. He also completed a fellowship in Endocrinology, Diabetes, and Metabolism at Rambam. A board certified specialist in both Internal Medicine and Endocrinology, Dr. Khamaisi completed a post-doctoral research fellowship at the Joslin Diabetes Center at Harvard Medical School, working with the Director of Research, George L. King, and head of the Vascular Cell Biology unit, and holds two patents from his work at Harvard.
As a member of the Clinical Research Institute of Rambam (CRIR), Dr. Khamaisi’s latest work in his lab continues to explore the molecular mechanisms involved in impaired wound healing in longstanding diabetes, particularly in chronic foot ulcer, a complication that leads to more than 2,000 amputations per year in Israel alone. He uses in vivo and in vitro studies, as well as human stem cells and other differentiated cells, to identify protective factors of diabetes-related vascular complications. His research currently utilizes inducible pluripotent stem cells (iPSCs) obtained from diabetics with longstanding disease, which differentiate into healthy endothelial cells and then are transplanted into a wound in an animal model.
Dr. Khamaisi has received numerous research grants and scientific awards, and has published over 75 scientific papers in prestigious international journals as well as book chapters and review articles.
